# Booking Holdings Inc.: overview

BKNG · Nasdaq · CIK 1075531 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkng.md) · [Financials](/companies/bkng/financials.md) · [Filings](/companies/bkng/filings.md) · [Insiders](/companies/bkng/insiders.md)

Latest reported revenue: [$7.35bn](/filings/0001075531-26-000037.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001075531-26-000037).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,994](/filings/0001075531-25-000051.md) | [5,471 d](/filings/0001075531-26-000009.md) | [4,762](/filings/0001075531-26-000025.md) | [6,798](/filings/0001075531-26-000037.md) | [9,008](/filings/0001075531-25-000051.md) | [6,349 d](/filings/0001075531-26-000009.md) | [5,532](/filings/0001075531-26-000025.md) | [7,352](/filings/0001075531-26-000037.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [39.8%](/filings/0001075531-25-000051.md) | [31.6% d](/filings/0001075531-26-000009.md) | [22.3%](/filings/0001075531-26-000025.md) | [33.1%](/filings/0001075531-26-000037.md) | [38.7%](/filings/0001075531-25-000051.md) | [32.0% d](/filings/0001075531-26-000009.md) | [23.0%](/filings/0001075531-26-000025.md) | [34.0%](/filings/0001075531-26-000037.md) |
| Net margin | % | [31.5%](/filings/0001075531-25-000051.md) | [19.5% d](/filings/0001075531-26-000009.md) | [7.0%](/filings/0001075531-26-000025.md) | [13.2%](/filings/0001075531-26-000037.md) | [30.5%](/filings/0001075531-25-000051.md) | [22.5% d](/filings/0001075531-26-000009.md) | [19.6%](/filings/0001075531-26-000025.md) | [26.5%](/filings/0001075531-26-000037.md) |
| Diluted EPS | $ per share | [74.34](/filings/0001075531-25-000051.md) | not reported | [0.40](/filings/0001075531-26-000025.md) | [1.10](/filings/0001075531-26-000037.md) | [84.41](/filings/0001075531-25-000051.md) | not reported | [1.36](/filings/0001075531-26-000025.md) | [2.53](/filings/0001075531-26-000037.md) |
| Free cash flow | $m | [2,296 d](/filings/0001075531-25-000051.md) | [645 d](/filings/0001075531-26-000009.md) | [3,162](/filings/0001075531-26-000025.md) | [3,137 d](/filings/0001075531-26-000037.md) | [1,371 d](/filings/0001075531-25-000051.md) | [1,417 d](/filings/0001075531-26-000009.md) | [3,108](/filings/0001075531-26-000025.md) | [3,643 d](/filings/0001075531-26-000037.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [11.0](/filings/0001075531-24-000014.md) | [17.1](/filings/0001075531-25-000010.md) | [21.4](/filings/0001075531-26-000009.md) | [23.7](/filings/0001075531-26-000009.md) | [26.9](/filings/0001075531-26-000009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [22.8%](/filings/0001075531-24-000014.md) | [29.9%](/filings/0001075531-25-000010.md) | [27.3%](/filings/0001075531-26-000009.md) | [31.8%](/filings/0001075531-26-000009.md) | [32.8%](/filings/0001075531-26-000009.md) |
| Net margin | % | [10.6%](/filings/0001075531-24-000014.md) | [17.9%](/filings/0001075531-25-000010.md) | [20.1%](/filings/0001075531-26-000009.md) | [24.8%](/filings/0001075531-26-000009.md) | [20.1%](/filings/0001075531-26-000009.md) |
| Diluted EPS | $ per share | [28.17](/filings/0001075531-24-000014.md) | [76.35](/filings/0001075531-25-000010.md) | [117.40](/filings/0001075531-26-000009.md) | [172.69](/filings/0001075531-26-000009.md) | [165.57](/filings/0001075531-26-000009.md) |
| Free cash flow | $bn | [2.5](/filings/0001075531-24-000014.md) | [6.2](/filings/0001075531-25-000010.md) | [7.0](/filings/0001075531-26-000009.md) | [7.9](/filings/0001075531-26-000009.md) | [9.1](/filings/0001075531-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bkng/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $11.65bn | 65,340,562 |  | Added +62,687,422 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.02bn | 50,606,248 |  | Added +48,529,812 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $7.76bn | 1,843,531 |  | Added +1,766,899 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $6.25bn | 35,038,703 |  | Added +33,617,907 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $4.59bn | 25,735,059 |  | Added +25,381,509 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $4.55bn | 25,536,950 |  | Added +24,539,452 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.92bn | 21,923,074 |  | Added +21,031,935 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $3.67bn | 20,614,112 |  | Added +19,844,951 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $3.44bn | 18,836,495 |  | Added +17,766,289 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.58bn | 14,456,785 |  | Added +13,867,396 |

## Recent filings

[All 1,491 filings](/companies/bkng/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 21:07 ET | [10-Q](/filings/0001075531-26-000037.md) | Quarterly report, period 2026-06-30 | 0001075531-26-000037 |
| 2026-08-04 | 20:03 ET | [8-K](/filings/0001075531-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075531-26-000036 |
| 2026-06-02 | 20:57 ET | [8-K](/filings/0001075531-26-000031.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001075531-26-000031 |
| 2026-05-11 | 21:01 ET | [8-K](/filings/0001104659-26-058730.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-058730 |
| 2026-05-07 | 20:49 ET | [8-K](/filings/0001104659-26-057239.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057239 |
| 2026-04-28 | 21:12 ET | [10-Q](/filings/0001075531-26-000025.md) | Quarterly report, period 2026-03-31 | 0001075531-26-000025 |
| 2026-04-28 | 20:03 ET | [8-K](/filings/0001075531-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001075531-26-000024 |
| 2026-04-21 | 20:01 ET | [DEF 14A](/filings/0001308179-26-000310.md) | Proxy statement, period 2026-06-02 | 0001308179-26-000310 |
| 2026-04-02 | 20:34 ET | [8-K](/filings/0000950157-26-000465.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950157-26-000465 |
| 2026-04-02 | 20:12 ET | [8-K](/filings/0001075531-26-000014.md) | 5.02 Departure or appointment of officers or directors | 0001075531-26-000014 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001075531-26-000009.md), filed Feb 18, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8f0a8f23-9e59-4a91-944a-a645561ce83d)

## About the filer

- CIK: 1075531
- Tickers: BKNG
- Exchange: Nasdaq
- SIC code: 4700 Transportation Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.